1.91
price down icon3.05%   -0.06
after-market Dopo l'orario di chiusura: 1.96 0.05 +2.62%
loading
Precedente Chiudi:
$1.97
Aprire:
$2
Volume 24 ore:
1.11M
Relative Volume:
0.63
Capitalizzazione di mercato:
$559.38M
Reddito:
$6.23M
Utile/perdita netta:
$-95.90M
Rapporto P/E:
-4.8974
EPS:
-0.39
Flusso di cassa netto:
$-68.47M
1 W Prestazione:
-2.55%
1M Prestazione:
+61.86%
6M Prestazione:
+60.50%
1 anno Prestazione:
+34.51%
Intervallo 1D:
Value
$1.87
$2.05
Intervallo di 1 settimana:
Value
$1.87
$2.17
Portata 52W:
Value
$0.6513
$2.17

Precigen Inc Stock (PGEN) Company Profile

Name
Nome
Precigen Inc
Name
Telefono
301-556-9900
Name
Indirizzo
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Name
Dipendente
202
Name
Cinguettio
@precigen
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
PGEN's Discussions on Twitter

Confronta PGEN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PGEN
Precigen Inc
1.91 559.38M 6.23M -95.90M -68.47M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-03-22 Downgrade JP Morgan Neutral → Underweight
2023-05-23 Iniziato JP Morgan Neutral
2022-11-18 Iniziato Cantor Fitzgerald Overweight
2021-02-25 Iniziato Stifel Buy
2021-02-22 Iniziato Wells Fargo Overweight
2021-02-18 Iniziato B. Riley Securities Buy
2020-05-08 Iniziato H.C. Wainwright Buy
Mostra tutto

Precigen Inc Borsa (PGEN) Ultime notizie

pulisher
Feb 20, 2025

Precigen, Inc. (PGEN) Just Flashed Golden Cross Signal: Do You Buy? - Nasdaq

Feb 20, 2025
pulisher
Feb 20, 2025

Precigen (NASDAQ:PGEN) Reaches New 1-Year HighHere's What Happened - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

Precigen (NASDAQ:PGEN) Stock Price Up 8.4%What's Next? - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Precigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Feb 19, 2025
pulisher
Feb 18, 2025

Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

Precigen, Inc. (NASDAQ:PGEN) Receives $7.00 Consensus Price Target from Brokerages - Defense World

Feb 17, 2025
pulisher
Feb 16, 2025

Precigen (NASDAQ:PGEN) Hits New 52-Week HighHere's What Happened - MarketBeat

Feb 16, 2025
pulisher
Feb 14, 2025

Will Precigen's Treatment For Recurrent Respiratory Papillomatosis Cross The FDA Finish Line? - RTTNews

Feb 14, 2025
pulisher
Feb 14, 2025

SG Americas Securities LLC Acquires 12,578 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World

Feb 14, 2025
pulisher
Feb 12, 2025

PGEN Stock Soars to 52-Week High, Reaching $1.93 Amid Growth - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Bought by Iridian Asset Management LLC CT - MarketBeat

Feb 12, 2025
pulisher
Feb 11, 2025

These Numbers Prove Just How Vibrant The Precigen Inc (NASDAQ: PGEN) Stock Has Been - Stocks Register

Feb 11, 2025
pulisher
Feb 11, 2025

Precigen (NASDAQ:PGEN) Shares Up 7.8%Here's Why - MarketBeat

Feb 11, 2025
pulisher
Feb 10, 2025

Precigen stock slides after pricing stock offering to raise $30 million - MSN

Feb 10, 2025
pulisher
Feb 10, 2025

Exploring 3 High Growth Tech Stocks in the United States - Simply Wall St

Feb 10, 2025
pulisher
Feb 10, 2025

Precigen Inc (NASDAQ: PGEN): Performance Review And Forecast - Marketing Sentinel

Feb 10, 2025
pulisher
Feb 10, 2025

Precigen: Successful Proof Of Platform, But Cash Worries Remain (NASDAQ:PGEN) - Seeking Alpha

Feb 10, 2025
pulisher
Feb 07, 2025

Precigen (NASDAQ:PGEN) Stock Price Up 7.8% – Time to Buy? - Armenian Reporter

Feb 07, 2025
pulisher
Feb 07, 2025

PGEN Shares Experience Surge in Value - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

Precigen Inc (NASDAQ: PGEN): Can A Stock Be Up 42.86% YTD, And Still Be A Loser - Marketing Sentinel

Feb 07, 2025
pulisher
Feb 06, 2025

A Deep Dive into Precigen Inc (PGEN) Stock Performance - The InvestChronicle

Feb 06, 2025
pulisher
Feb 04, 2025

JP Morgan analysts downgrades an Underweight rating for Precigen Inc (PGEN) - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

Is Precigen Inc (PGEN) a good investment opportunity? - US Post News

Feb 04, 2025
pulisher
Jan 27, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Sold by JPMorgan Chase & Co. - MarketBeat

Jan 27, 2025
pulisher
Jan 27, 2025

JPMorgan Chase & Co. Decreases Stake in Precigen, Inc. (NASDAQ:PGEN) - Defense World

Jan 27, 2025
pulisher
Jan 27, 2025

FY2024 EPS Estimates for Precigen Lifted by HC Wainwright - Defense World

Jan 27, 2025
pulisher
Jan 26, 2025

HC Wainwright Has Weak Outlook for Precigen FY2026 Earnings - Defense World

Jan 26, 2025
pulisher
Jan 26, 2025

Precigen’s (PGEN) Buy Rating Reiterated at HC Wainwright - Defense World

Jan 26, 2025
pulisher
Jan 24, 2025

Investors Purchase High Volume of Call Options on Precigen (NASDAQ:PGEN) - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

LexAurum Advisors LLC Raises Stock Holdings in Precigen, Inc. (NASDAQ:PGEN) - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

FY2026 EPS Estimates for Precigen Decreased by HC Wainwright - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Precigen (NASDAQ:PGEN) Earns Buy Rating from HC Wainwright - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Precigen Sees Unusually Large Options Volume (NASDAQ:PGEN) - Defense World

Jan 24, 2025
pulisher
Jan 23, 2025

Precigen's SWOT analysis: biotech firm's stock poised for growth with PRGN-2012 - MSN

Jan 23, 2025
pulisher
Jan 23, 2025

Knight-Swift Transportation Posts Upbeat Earnings, Joins TAL Education, LSI Industries, GE Aerospace And Other Big Stocks Moving Higher On Thursday - Benzinga

Jan 23, 2025
pulisher
Jan 23, 2025

Precigen (NASDAQ:PGEN) Given Buy Rating at HC Wainwright - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Precigen, Inc. (NASDAQ:PGEN) Stock Position Increased by Barclays PLC - Defense World

Jan 23, 2025
pulisher
Jan 23, 2025

Analysts Set Precigen, Inc. (NASDAQ:PGEN) Price Target at $6.33 - Defense World

Jan 23, 2025
pulisher
Jan 20, 2025

Precigen, Inc. (NASDAQ:PGEN) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 20, 2025
pulisher
Jan 19, 2025

Precigen, Inc. Regains Compliance with Nasdaq Listing Rules - Defense World

Jan 19, 2025
pulisher
Jan 18, 2025

Precigen shares rebound above Nasdaq minimum bid price - MSN

Jan 18, 2025
pulisher
Jan 16, 2025

Precigen shares rebound above Nasdaq minimum bid price By Investing.com - Investing.com Australia

Jan 16, 2025
pulisher
Jan 16, 2025

Should You Invest in Precigen (PGEN)? - MSN

Jan 16, 2025

Precigen Inc Azioni (PGEN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Precigen Inc Azioni (PGEN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
KIRK RANDAL J
Director
Aug 09 '24
Buy
0.85
23,529,411
19,999,999
64,547,214
KIRK RANDAL J
Director
Mar 09 '24
Option Exercise
0.00
213,675
0
32,051,461
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
Capitalizzazione:     |  Volume (24 ore):